These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25242405)

  • 1. Detection of a novel neurotoxic metabolite of Parkinson's disease-related neurotoxin, 1-benzyl-1,2,3,4- tetrahydroisoquinoline.
    Kotake Y; Sekiya Y; Okuda K; Ohta S
    J Toxicol Sci; 2014; 39(5):749-54. PubMed ID: 25242405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline binds with tubulin beta, a substrate of parkin, and reduces its polyubiquitination.
    Kohta R; Kotake Y; Hosoya T; Hiramatsu T; Otsubo Y; Koyama H; Hirokane Y; Yokoyama Y; Ikeshoji H; Oofusa K; Suzuki M; Ohta S
    J Neurochem; 2010 Sep; 114(5):1291-301. PubMed ID: 20067570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances].
    Kotake Y
    Yakugaku Zasshi; 2002 Nov; 122(11):975-82. PubMed ID: 12440154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.
    Wąsik A; Romańska I; Michaluk J; Kajta M; Antkiewicz-Michaluk L
    Neurotox Res; 2014 Oct; 26(3):240-54. PubMed ID: 24842650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
    Xie B; Lin F; Ullah K; Peng L; Ding W; Dai R; Qing H; Deng Y
    Biochem Biophys Res Commun; 2015 Apr; 459(3):361-6. PubMed ID: 25744031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
    Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2009 Jan; 15(1):15-23. PubMed ID: 19384584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S; Carlson EC; Swinscoe JC; Ebadi M
    J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain].
    Ohta S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Feb; 25(1):39-42. PubMed ID: 15796069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis.
    Shavali S; Ebadi M
    Neurotoxicology; 2003 Jun; 24(3):417-24. PubMed ID: 12782106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
    Kotake Y; Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1995 Dec; 65(6):2633-8. PubMed ID: 7595560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-dependent opposite effects of 1-benzyl-1,2,3,4-tetrahydroisoquinoline on markers of apoptosis: in vitro and ex vivo studies.
    Wąsik A; Kajta M; Lenda T; Antkiewicz-Michaluk L
    Neurotox Res; 2014 Jan; 25(1):90-9. PubMed ID: 24190811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain.
    Song Y; Xu J; Hamme A; Liu YM
    J Chromatogr A; 2006 Jan; 1103(2):229-34. PubMed ID: 16310796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.
    Kotake Y; Yoshida M; Ogawa M; Tasaki Y; Hirobe M; Ohta S
    Neurosci Lett; 1996 Oct; 217(1):69-71. PubMed ID: 8905742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease.
    Abe K; Saitoh T; Horiguchi Y; Utsunomiya I; Taguchi K
    Biol Pharm Bull; 2005 Aug; 28(8):1355-62. PubMed ID: 16079473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of 17 tetrahydroisoquinoline derivatives in SH-SY5Y human neuroblastoma cells is related to mitochondrial NADH-ubiquinone oxidoreductase inhibition.
    Kotake Y; Sekiya Y; Okuda K; Ohta S
    Neurotoxicology; 2007 Jan; 28(1):27-32. PubMed ID: 16860391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
    Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
    J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
    Kajita M; Niwa T; Fujisaki M; Ueki M; Niimura K; Sato M; Egami K; Naoi M; Yoshida M; Nagatsu T
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):345-51. PubMed ID: 7581910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.